Products - Eczema | Topic | NICE

Showing 5 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over ID6221
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
21 May 2025
Tralokinumab for treating moderate to severe atopic dermatitis [ID3734]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Upadacitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3733]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Delgocitinib for treating moderate to severe chronic hand eczema ID6408
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC